Reuters logo
BRIEF-Jiangxi Boya Bio-Pharmaceutial sees Q1 FY 2017 net profit up 60 pct to 90 pct
March 23, 2017 / 7:13 AM / 9 months ago

BRIEF-Jiangxi Boya Bio-Pharmaceutial sees Q1 FY 2017 net profit up 60 pct to 90 pct

March 23 (Reuters) - Jiangxi Boya Bio-Pharmaceutial Co Ltd

* Sees Q1 FY 2017 net profit to increase by 60 percent to 90 percent, or to be 61.7 million yuan to 73.2 million yuan

* Says Q1 FY 2016 net profit was 38.5 million yuan

* The reason for the forecast is blood products business growth, investment income and tax refund

Source text in Chinese:goo.gl/oGySFn

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below